SCHEMBL23529318

SCHEMBL23529318

COc1c(C(N)=O)cc(F)c(F)c1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
GRIN3A Q8TCU5 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 4/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
MITF O75030 1/20 0.38
HTT P42858 1/20 0.38
CCR6 P51684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23529328 0.81 PKM (0.39) PKMTDP1KDM4EPOLBCTDSP1
SCHEMBL16689315 0.78 PKM (0.57) PKMTDP1KDM4EPOLBCTDSP1
SCHEMBL999442 0.78 KMT2A (0.40) TDP1KDM4EPOLBCTDSP1L3MBTL1
SCHEMBL15486324 0.78 ALDH1A1 (0.50) PKMTDP1KDM4EPOLBCTDSP1
SCHEMBL27816651 0.77 SMN1; SMN2 (0.50) PKMTDP1KDM4EPOLBCTDSP1
SCHEMBL24639499 0.76 GRIN2D (0.50) PKMTDP1L3MBTL1GRIN2DGRIN3B
SCHEMBL30626632 0.76 GRIN2D (0.50) PKMTDP1L3MBTL1GRIN2DGRIN3B
SCHEMBL3337229 0.76 ROCK2 (0.38) KDM4EPOLBALDH1A1LMNAHTT
SCHEMBL25395311 0.75 PKM (0.43) PKMTDP1KDM4EPOLBCTDSP1
SCHEMBL30626641 0.75 GRIN2D (0.51) PKMTDP1KDM4EGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132112-A1 COMPOUNDS CTXT PTY LTD (AU) 2026-05-14 US disclosed
EP-4077318-B1 BENZIMIDAZOLE DIMERS AS MODULATORS OF STING CTXT PTY LTD (AU) 2025-10-15 EP disclosed
US-12415785-B2 Compound modulators of sting CTXT PTY LTD (AU) 2025-09-16 US disclosed
CN-114981265-B Compounds of formula (I) CTXT私人有限公司 2025-01-03 CN disclosed
US-20230062932-A1 COMPOUNDS CTXT PTY LTD. (AU) 2023-03-02 US disclosed
WO-2022266711-A1 SUBSTITUTED AMIDOBENZIMIDAZOLE DIMERS AS STING MODULATORS Aculeus Therapeutics Pty Ltd (AU) 2022-12-29 WO disclosed
EP-4077318-A1 COMPOUNDS CTXT PTY LTD (AU) 2022-10-26 EP disclosed
CN-114981265-A Compound (I) CTXT私人有限公司 2022-08-30 CN disclosed
WO-2021119753-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415785-B2 Compound modulators of sting STING1, IRF3, MAVS PKM 2557/4885TDP1 533/4885KDM4E 3167/4885
US-20260132112-A1 COMPOUNDS STING1, IRF3, CGAS PKM 4052/4885TDP1 112/4885KDM4E 3370/4885
US-20230062932-A1 COMPOUNDS STING1, IRF3, MAVS PKM 2775/4885TDP1 404/4885KDM4E 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.